• Press
  • Offices
  • Contact
  • Legal notice
  • LinkedIn
  • EN
    • DE
  • UPC
  • Firm
    • Main Focus
    • History
    • Guiding Principle
    • Code of Conduct
    • Awards and Rankings
  • Our Team
  • News & Knowledge
    • News
    • Events
    • UPC-Update
    • IP-Update
    • EmpCo Directive
    • Publications
    • Subscription B&B Bulletin
  • Our Practice
    • Legal Areas
    • Industries
  • Career
  • Menu Menu
FIND EXPERTS
  • UPC
  • Firm
  • News & Knowledge
    • News
    • Events
    • UPC-Update
    • IP-Update
    • EmpCo Directive
    • Publications
    • B&B Bulletin
  • FIND EXPERTS
  • Contact
  • Offices
  • Our Practice
  • Career
  • EN
    • DE
  • Legal Areas
  • Industries
Scales of justice representing the Unified Patent Court (UPC) and current developments in European patent litigation

Court of Appeal extends jurisdiction of the Central Division for infringement actions

29. July 2026/in UPC-Update Patent Litigation

New jurisdiction rules open up additional litigation options. Patent holders now have more flexibility in choosing a court.

In public discourse around the UPC, the Local Divisions are associated with infringement actions and the Central Divisions with stand-alone nullity actions.

However, the Central Division (with sections in Paris, Munich and Milan, whereas their competence depends on the IPC class of the patent-in-suit) is competent to hear infringement actions in case the defendant is domiciled outside of UPC territory and also lacks a principal or any place of business thereon (Art. 33 para.1 subpara 3 UPCA).

As there is no scenario where the Central Division is competent to hear an infringement action but a Local (or Regional) Division is not (as an infringement action requires an actual infringement or threat thereof, meaning a Local Division is always competent to hear the case pursuant to Art. 33 para.1 lit.a) UPCA), a patent holder has the right to choose between a Local Division and the Central Division in scenarios where the Central Division is competent.

However, in light of the apparent limitations above (no domicile or place of business of the defendant in UPC territory), it appeared that the number of scenarios where the Central Division is competent in the first place was limited, since usually there is a multitude of defendants (in order to cover the whole supply chain), and usually at least one of the defendants has its domicile or place of business on the territory of the UPCA.

Therefore, the question whether Art. 33 para.1 subpara 3 UPCA also applies in cases where at least one of the defendants is domiciled outside of UPC territory, even if the other defendants are domiciled within, reached the Court of Appeal.

The Court of Appeal answered this question with a yes (UPC-CoA-4/2026. UPC-CoA-13/2026, order of 22 June 2026[1]. The provision was held to be not an exception but an alternative to the jurisdiction of the Local Divisions, as its wording contains no corresponding limitation. The anchor-defendant mechanism of Art. 33 para.1 lit.b) UPCA was argued to apply by way of analogy. The stated purpose is to avoid parallel proceedings and conflicting decisions as otherwise cases might have to be brought before several Local Divisions.

The Court of Appeal therefore extends the competence of the Central Division significantly.

For patent holders who now have the right to choose between a Local Division and the Central Division, specifically the following strategic considerations apply:

  • Familiarity with and expertise of the legal judges of the Central Division: this applies especially where the competent Local Division would be a division with a low case number, where the case management and legal opinions of the judges might not be easily foreseeable
  • Language: before the Central Division, the language of the patent-in-suit applies. This may e.g. be a consideration for German SMEs who have filed their EPs in German, and where German is not a language which the competent Local Division offers.

Source: [1] https://www.unifiedpatentcourt.org/sites/default/files/files/api_order/ORDER_VALEO%20v%20BOSCH_004%20and%20013-2026_2026-06-22_FR_Signed.pdf

https://www.boehmert.de/wp-content/uploads/2026/07/UPC-Update-boehmert.jpg 598 650 Petra Hettenkofer /wp-content/uploads/2022/04/boehmert_logo.svg Petra Hettenkofer2026-07-29 13:43:392026-07-29 14:03:37Court of Appeal extends jurisdiction of the Central Division for infringement actions
Hamburg waterfront at sunset with the Elbphilharmonie

Meet us at The Port of Hamburg by Night on October 8, 2026!

28. July 2026/in Uncategorized

As part of AIPPI 2026 in Hamburg, we are delighted to invite you to an unforgettable evening at one of the city’s most iconic waterfront locations. Enjoy a relaxed dinner overlooking the Elbphilharmonie, followed by optional one-hour harbor cruises through the Port of Hamburg. We look forward to sharing this special evening with you!

Read more
https://www.boehmert.de/wp-content/uploads/2026/06/BB-Event-Hamburg-2026-Web.jpg 480 1000 Petra Hettenkofer /wp-content/uploads/2022/04/boehmert_logo.svg Petra Hettenkofer2026-07-28 09:30:372026-07-28 10:29:40Meet us at The Port of Hamburg by Night on October 8, 2026!
Portraits of Minsun Song and Dr. Fabian Schmidt to announce that they have passed the EQE exam.

Minsun Song and Dr. Fabian Schmidt pass the European Qualifying Examination

23. July 2026/in News

Deciding to pursue several years of additional training after successfully completing one’s studies and while juggling a demanding professional life requires a great deal of dedication and perseverance. We are therefore all the more pleased that two of our young colleagues took on this challenge and successfully passed the European Qualifying Examination (EQE).

Once all formalities have been completed, Minsun Song and Dr. Fabian Schmidt will be entitled to use the title “European Patent Attorney.” They will then be authorized representatives before the European Patent Office.

Minsun Song has been with BOEHMERT & BOEHMERT since 2022. A materials scientist by training, she handles application and examination proceedings before the European Patent Office and the German Patent and Trademark Office – with a particular focus on the fields of semiconductor technology, materials science, rechargeable batteries, and optics.

Dr. Fabian Schmidt handles all aspects of patent grant proceedings, including the drafting of patent applications and responding to examination reports in proceedings before the European Patent Office, the German Patent and Trademark Office, and foreign patent offices. His technical expertise spans numerous disciplines within the life sciences industry, particularly biotechnology, biochemistry, immunology, molecular biology, pharmacy, cell biology, and microbiology.

We are proud of the achievements of our two dedicated colleagues and warmly congratulate Minsun Song and Dr. Fabian Schmidt on this important milestone in their professional careers. We wish them every success in the future and look forward to continuing to accompany them on their career journey.

Minsun Song & Dr. Fabian Schmidt

Minsun Song, Patent Engineer at BOEHMERT & BOEHMERT
Minsun Song, Patent Engineer at BOEHMERT & BOEHMERT
Dr. Fabian Schmidt, Patent Attorney at BOEHMERT & BOEHMERT
Dr. Fabian Schmidt, Patent Attorney at BOEHMERT & BOEHMERT

 

 

https://www.boehmert.de/wp-content/uploads/2026/07/Minsun-Song-und-Dr.-Fabian-Schmidt.jpg 791 1200 Petra Hettenkofer /wp-content/uploads/2022/04/boehmert_logo.svg Petra Hettenkofer2026-07-23 10:56:192026-07-23 13:30:05Minsun Song and Dr. Fabian Schmidt pass the European Qualifying Examination
Dr. Julian Wernicke, Attorney at Law at BOEHMERT & BOEHMERT

Dr. Julian Wernicke in GRUR Prax 13/2026 on the General Court’s decision in “LAMUCCA v. MUKA”

16. July 2026/in Publications

The General Court’s decision in “LAMUCCA v. MUKA” (T-390/25) provides interesting clarifications regarding the likelihood of confusion in the context of service marks, the weight given to phonetic similarities between marks, and the significance of foreign-language terminology in trademark practice.

In his article „LAMUCCA gegen MUKA: Verwechslungsgefahr durch Klangnähe bei Dienstleistungsmarken“ (LAMUCCA v. MUKA: Likelihood of Confusion Due to Phonetic Similarity in Service Marks) in GRUR Prax 13/2026, Julian Wernicke, an attorney at law at BOEHMERT & BOEHMERT, analyzes the decision of the General Court of the European Union in the case “LAMUCCA v. MUKA,” in which the court confirmed the invalidity of the EU figurative mark MUKA due to a likelihood of confusion with the earlier Spanish mark LAMUCCA.

The ruling makes it clear that even where there is only a slight visual similarity, a high degree of phonetic similarity may be sufficient to establish a likelihood of confusion. In the conceptual comparison of trademarks, meanings in foreign languages may be taken into account only if they are actually understood by a significant portion of the relevant public. Furthermore, the court clarifies the requirements for proving use of service marks that preserves the rights associated with them.

The full article by Julian Wernicke, which includes helpful practical guidance, is available here in German to registered users of Beck Online.

https://www.boehmert.de/wp-content/uploads/2023/05/Wernicke-Julian-Portrait-Web.jpg 667 1000 Petra Hettenkofer /wp-content/uploads/2022/04/boehmert_logo.svg Petra Hettenkofer2026-07-16 17:05:182026-07-16 19:06:25Dr. Julian Wernicke in GRUR Prax 13/2026 on the General Court’s decision in “LAMUCCA v. MUKA”
Scales of justice representing the Unified Patent Court (UPC) and current developments in European patent litigation

Local Division Dusseldorf endorses the Plant-e v. Arkyne test for assessing equivalence

9. July 2026/in UPC-Update

The validation of the Plant-e-Test by a German Local Division paves the way for the standardization of equivalence rulings at the UPC.

In Wonderland v. Cybex, concerning the infringement of patents relating to child seats and strollers (UPC_CFI_807/2024 and UPC_CFI_334/2025, decision of 27 May 2026), the Local Division (LD) Düsseldorf confirmed that the test for assessing equivalent infringement developed by the LD The Hague (UPC_CFI_239/2023, decision of 22 November 2024, para. 88 – Plant-e v. Arkyne) forms a coherent whole and is as such suitable for the examination of equivalence (Headnote 1).

This makes Wonderland v. Cybex one of the first UPC decisions to examine equivalence on the merits – and the first in which a German Local Division applies the largely Dutch-inspired Plant-e framework rather than the competing German Schneidmesser approach. The position of the Plant-e test as the emerging UPC standard has thereby been strengthened considerably, although the Court of Appeal (CoA) has yet to rule on the issue.

Competing approaches to equivalence

The Plant-e test consists of four questions: (1) Technical equivalence – does the variation solve (essentially) the same problem as the patented invention and perform (essentially) the same function? (2) Fair protection – is extending protection to the equivalent proportionate to a fair protection for the patentee, in view of his contribution to the art and of whether it is obvious to the skilled person from the patent how to apply the equivalent element (at the time of infringement)? (3) Reasonable legal certainty for third parties – does the skilled person understand from the patent that the scope of the invention is broader than what is claimed literally? (4) Is the allegedly infringing product novel and inventive over the prior art?

The German Schneidmesser test (BGH, decision of 12 March 2002, X ZR 168/00 – Schneidmesser I) asks: (1) Equal effect – do the modified means objectively perform essentially the same function as the claimed feature? (2) Findability – was the skilled person able, at the priority date and without inventive considerations, to identify the modified means as performing that function? (3) Orientation along the patent claim – are the skilled person’s considerations oriented along the claim such that the modified means are regarded as an equivalent solution within the meaning of the patent? A fourth question, sometimes treated as part of the canon, asks whether the description discloses the modified means but ultimately excludes them, whether by omission from the claim or by outright rejection.

Where the two tests actually diverge

The decision contrasts the “holistic” Dutch approach with the “legal-technical” German approach. In practical terms, this shorthand translates into three concrete differences:

First, the reference date.

Under Schneidmesser, the modified means must have been findable at the priority date; under Plant-e, it suffices that applying the equivalent element was obvious at the time of infringement. Post-priority technical knowledge can therefore support equivalence under the Dutch test but not under the German one – structurally, Plant-e is the broader standard, and this difference alone can be outcome-determinative, particularly for older patents in fast-moving fields.

Second, the yardstick: claim primacy versus fairness balancing.

The decisive third Schneidmesser question ties equivalence strictly to the patent claim: even a technically equivalent, readily findable variant falls outside the scope of protection where the claim wording reflects a deliberate narrowing choice by the patentee. Plant-e has no such claim-orientation filter; it instead balances fair protection for the patentee against legal certainty for third parties. Put pointedly: in borderline cases the German test asks what the claim permits, the Dutch test asks what result is fair.

Third, the role of the prior art.

Plant-e integrates the novelty and inventiveness of the attacked embodiment over the prior art directly into the test (question 4). In German practice, this corresponds to the separate Formstein defence, which must be raised by the defendant and is not part of the equivalence test itself – with corresponding consequences for the structure and burden of the parties’ pleadings.

The German clarification

On technical equivalence, the LD Düsseldorf clarified that the claimant must not focus solely on the objective problem of the patent in suit, but must demonstrate the function of each substituted feature in achieving that objective and explain why the variation performs essentially the same function (Headnote 2). This mirrors the first Schneidmesser question and reads a distinctly German, feature-by-feature technical discipline into the first question of the Dutch test. On the second Plant-e question, the panel held – rather self-evidently – that applying the equivalent element is not obvious where it would require a complete redesign of the claimed device (Headnote 3, para. 263). Beyond this, the court did not deviate from the approach of the LD The Hague.

Endorsement – with a caveat

The endorsement by a German Local Division carries weight. One passage, however, counsels against reading the decision as a landmark ruling: the panel expressly noted that there is no indication that applying a different standard than the Plant-e test would have produced a different result in the case at hand (para. 240). The adoption of the Dutch framework was thus outcome-neutral; the panel did not decide that Plant-e must prevail where the two tests genuinely diverge – for instance on the reference date. That question remains open, ultimately for the CoA. The decision is therefore best read not as a defeat of the German approach, but as a step towards convergence: a German Local Division applying the Dutch framework while injecting German technical rigour into its first question. The direction of travel towards a uniform UPC test for equivalence has become clearer; its final destination has not yet been fixed.

https://www.boehmert.de/wp-content/uploads/2026/07/UPC-Update-boehmert.jpg 598 650 Petra Hettenkofer /wp-content/uploads/2022/04/boehmert_logo.svg Petra Hettenkofer2026-07-09 11:58:402026-07-13 09:20:44Local Division Dusseldorf endorses the Plant-e v. Arkyne test for assessing equivalence
Dr. Ute Kilger, Patent Attorney at BOEHMERT & BOEHMERT

transkript: Dr. Ute Kilger on clarity ob­jec­tions in Euro­pean patent grant pro­ceedings

6. July 2026/in Publications Patents and Utility Models

Why excessive clarity requirements can undermine the value of patents

In issue 2/2026 of the life sciences magazine transkript, BOEHMERT & BOEHMERT Partner and Patent Attorney Dr. Ute Kilger examines a development that many patent applicants before the European Patent Office (EPO) are increasingly viewing with concern in her article “Clarity as a deadly wonder weapon”.

The article focuses on the question of how so-called clarity objections under Article 84 EPC are applied during examination proceedings. As a patent attorney specializing in pharmaceuticals and life sciences, Dr. Ute Kilger regularly advises companies and research institutions in European patent grant proceedings and is well acquainted with the practical challenges before the European Patent Office through many years of experience.

Using practical examples from the fields of diagnostics and antibody development, the article illustrates how extensive clarity requirements can affect the commercial value and future enforceability of patents. Excessive limitations on patent claims may result in patent rights losing their effectiveness against imitators and so-called fast followers.

Dr. Kilger therefore advocates a balanced and consistent application of clarity requirements in patent examination proceedings. At the same time, she encourages patent applicants to make active use of existing communication channels with the European Patent Office in order to raise awareness of problematic developments and foster constructive dialogue.

The full article, “Clarity as a deadly wonder weapon”, was published in the current issue of transkript and is available to subscribers in German.
https://www.boehmert.de/wp-content/uploads/2022/06/Kilger-Ute-Portrait-Web.jpg 667 1000 Lucia Biehl /wp-content/uploads/2022/04/boehmert_logo.svg Lucia Biehl2026-07-06 10:34:412026-07-06 10:38:07transkript: Dr. Ute Kilger on clarity ob­jec­tions in Euro­pean patent grant pro­ceedings
Seal certifying a ranking in the Leaders League for the year 2026

Leaders League 2026: BOEHMERT & BOEHMERT recognized as a leading IP law firm in two categories

2. July 2026/in Awards & Rankings

“Leading” designation in the practice areas of patent and trademark prosecution. Outstanding ratings and recommendations in six additional practice areas.

Once again this year, the Leaders League jury has rated BOEHMERT & BOEHMERT as “leading” in the areas of patent and trademark prosecution, and thus as one of the best IP law firms in Germany.
This means that the patent attorneys Christoph Angerhausen, Christian W. Appelt, Dr. Markus Engelhard, Dr. Jin Jeon, Dr. Steffen Schmidt, Dr. Volker Scholz, and Dr. Jakob Valvoda, as well as the attorneys at law Peter Gross, Dr. Florian Schwab, and Dr. Martin Wirtz, have received the highest possible recognition from the rating agency.

Dr. Rudolf Böckenholt, Dr. Andreas Dustmann, Silke Freund, Dr. Carl-Richard Haarmann, and Dr. Eckhard Ratjen can celebrate receiving an “Excellent” rating for their work in the area of “Trademark Litigation.”

With the rating “Highly recommended,” the jury honors the work of Dr. Markus Engelhard, Dr. Ute Kilger, Dr. Karl-Heinz Metten, and Dr. Volker Scholz in the “Healthcare & Pharmaceuticals” category.

In addition, the jury has issued recommendations for the following attorneys at BOEHMERT & BOEHMERT:
– Dr. Sebastian Engels, Dr. Carl-Richard Haarmann and Dr. Michael Rüberg for „Patent Litigation“;
– Dr. Rudolf Böckenholt, Silke Freund und Dr. Martin Schaefer for their achievements in the „Media, Sports & Entertainment“ sector;
– Dr. Andreas Dustmann, Dr. Sebastian Engels, Dr. Matthias Hofmann, Dr. Eckhard Ratjen und Dr. Jakob Valvoda for „IT & Outsourcing“ as well as
– Dr. Sebastian Engels, Dr. Eckhard Ratjen, Dr. Michael Rüberg und Dr. Alexander Thamer for their work in the field of „Data Protection“.

With the guiding principle “Excellence in Leadership and Management”, Leaders League sees itself as a media and rating agency for top executives on an international level and provides up-to-date news and analyses as well as directories on companies, rankings, specialist events and digital products.
The latest rankings from BOEHMERT & BOEHMERT are available on the Leaders League website.

https://www.boehmert.de/wp-content/uploads/2026/07/Leaders-League-2026.png 500 500 Petra Hettenkofer /wp-content/uploads/2022/04/boehmert_logo.svg Petra Hettenkofer2026-07-02 16:47:582026-08-11 12:21:30Leaders League 2026: BOEHMERT & BOEHMERT recognized as a leading IP law firm in two categories

Financial Times recommends BOEHMERT & BOEHMERT again as one of Europe’s leading patent law firms

1. July 2026/in Awards & Rankings

Recognition in the “Europe’s Leading Patent Law Firms 2026” ranking

BOEHMERT & BOEHMERT has again been recommended by the Financial Times as one of Europe’s leading patent law firms in 2026. The British business newspaper has published the “Europe’s Leading Patent Law Firms” ranking together with the independent market research company Statista since 2019. BOEHMERT & BOEHMERT has been listed in the ranking since its first edition.

In the current ranking, BOEHMERT & BOEHMERT is recommended both in the overall “Europe’s Leading Patent Law Firms” list and in five of six technology sectors. The firm is listed in Biotechnology, Food & Healthcare, Chemistry & Pharmacy, Electrical Engineering & Physics, IT & Software as well as Mechanical Engineering. This recognition once again highlights the firm’s visibility in the European patent market and the broad technical scope of its advisory practice.
For clients, the recognition provides an independent indication of the firm’s long-standing experience in developing, protecting and enforcing technical IP rights. It also confirms BOEHMERT & BOEHMERT’s continued presence in a ranking based on market feedback.

The full overview is available in the Financial Times ranking “Europe’s Leading Patent Law Firms 2026”. Further information on awards and rankings of BOEHMERT & BOEHMERT can be found in our Awards & Rankings section.

Methodology

For the “Europe’s Leading Patent Law Firms 2026” ranking, Statista surveyed patent experts and clients in Europe on behalf of the Financial Times. Participants were able to recommend law firms active in patent prosecution and patent strategy consulting. The assessment covers both the overall ranking and six technology sectors: Biotechnology, Food & Healthcare, Chemistry & Pharmacy, Electrical Engineering & Physics, IT & Software, Materials & Nanotechnology and Mechanical Engineering. Self-recommendations were not included in the evaluation. Statista also took measures to prevent multiple participation.

/wp-content/uploads/2022/04/boehmert_logo.svg 0 0 Lucia Biehl /wp-content/uploads/2022/04/boehmert_logo.svg Lucia Biehl2026-07-01 10:03:042026-07-01 10:12:20Financial Times recommends BOEHMERT & BOEHMERT again as one of Europe’s leading patent law firms

Latest posts

  • Scales of justice representing the Unified Patent Court (UPC) and current developments in European patent litigation
    Court of Appeal extends jurisdiction of the Central Division for infringement actions29. July 2026 - 13:43
  • Hamburg waterfront at sunset with the Elbphilharmonie
    Meet us at The Port of Hamburg by Night on October 8, 2026!28. July 2026 - 9:30
  • Portraits of Minsun Song and Dr. Fabian Schmidt to announce that they have passed the EQE exam.
    Minsun Song and Dr. Fabian Schmidt pass the European Qualifying Examination23. July 2026 - 10:56

Categories

Archive

Menu

  • Firm
  • Our Practice
  • Career
  • News & Knowledge
  • LinkedIn
  • FIND EXPERTS

Informations

  • Press
  • Contact
  • Legal notice
  • Data Protection
  • General Terms and Conditions
  • Subscription B&B Bulletin
  • Contact

Legal Areas

  • Employee Inventions
  • Data Protection
  • Designs
  • Domains
  • Information Technology
  • Anti-Trust
  • Licensing
  • Trade Marks
  • Patent Valuation
  • Patents & Utility Models
  • Patent Litigation
  • Product Piracy
  • Copyright
  • Unfair Competition

© Copyright 2026– BOEHMERT & BOEHMERT

Scroll to top Scroll to top Scroll to top